0001593968-19-000213.txt : 20190124 0001593968-19-000213.hdr.sgml : 20190124 20190124160353 ACCESSION NUMBER: 0001593968-19-000213 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190122 FILED AS OF DATE: 20190124 DATE AS OF CHANGE: 20190124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZERBE ROBERT L MD CENTRAL INDEX KEY: 0001220363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 19540039 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2019-01-22 0000887359 Vericel Corp VCEL 0001220363 ZERBE ROBERT L MD C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true false false false Common Stock 2019-01-22 4 M false 17500 2.63 A 17545 D Stock Option (right to buy) 2.63 2019-01-22 4 M false 17500 0 D 2027-05-03 Common Stock 17500 0 D These options, representing the right to purchase a total of 17,500 shares, became exercisable in equal monthly installments, contingent upon continued service to the Company, with the first vesting date on June 3, 2017, which was one month after the date on which the option was granted. /s/ Dominick C. Colangelo, Attorney-in-Fact for Robert Zerbe 2019-01-24